Cargando…

The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord Blood

OBJECTIVE: The peroxisome proliferator-activated receptors (PPARs) are a group of nu- clear receptor proteins whose functions as transcription factors regulate gene expres- sions. PPARs play essential roles in the regulation of cellular differentiation, development, and metabolism (carbohydrate, lip...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbasi, Parvaneh, Shamsasenjan, Karim, Movassaghpour Akbari, Ali Akbar, Akbarzadehlaleh, Parvin, Dehdilani, Nima, Ejtehadifar, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393663/
https://www.ncbi.nlm.nih.gov/pubmed/25870831
_version_ 1782366198082568192
author Abbasi, Parvaneh
Shamsasenjan, Karim
Movassaghpour Akbari, Ali Akbar
Akbarzadehlaleh, Parvin
Dehdilani, Nima
Ejtehadifar, Mostafa
author_facet Abbasi, Parvaneh
Shamsasenjan, Karim
Movassaghpour Akbari, Ali Akbar
Akbarzadehlaleh, Parvin
Dehdilani, Nima
Ejtehadifar, Mostafa
author_sort Abbasi, Parvaneh
collection PubMed
description OBJECTIVE: The peroxisome proliferator-activated receptors (PPARs) are a group of nu- clear receptor proteins whose functions as transcription factors regulate gene expres- sions. PPARs play essential roles in the regulation of cellular differentiation, development, and metabolism (carbohydrate, lipid, protein), and tumorigenesis of higher organisms. This study attempts to determine the effect of baicalin, a PPARγ activator, on erythroid differentiation of cluster of differentiation 133(+)(CD133(+)) cord blood hematopoietic stem cells (HSCs). MATERIALS AND METHODS: In this experimental study, in order to investigate the effects of the PPARγ agonists baicalin and troglitazone on erythropoiesis, we isolated CD133(+) cells from human umbilical cord blood using the MACS method. Isolated cells were cultured in erythroid-inducing medium with or without various amounts of the two PPARγ activa- tors (baicalin and troglitazone). Erythroid differentiation of CD133(+)cord blood HSCs were assessed using microscopic morphology analysis, flow cytometric analysis of erythroid surface markers transferrin receptor (TfR) and glycophorin A (GPA) and bycolony forming assay. RESULTS: Microscopic and flow cytometric analysis revealed the erythroid differentiation of CD133(+)cord blood HSCs under applied erythroid inducing conditions. Our flow cytometric data showed that the TfR and GPA positive cell population diminished significantly in the presence of either troglitazone or baicalin. The suppression of erythroid differentiation in response to PPARγ agonists was dose-dependent. Erythroid colony-forming ability of HSC decreased significantly after treatment with both PPARγ agonists but troglitazone had a markedly greater effect. CONCLUSION: Our results have demonstrated that PPARγ agonists modulate erythroid dif- ferentiation of CD133(+)HSCs, and therefore play an important role in regulation of normal erythropoiesis under physiologic conditions. Thus, considering the availability and applica- tion of this herbal remedy for treatment of a wide range of diseases, the inhibitory effect of baicalin on erythropoiesis should be noted.
format Online
Article
Text
id pubmed-4393663
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Royan Institute
record_format MEDLINE/PubMed
spelling pubmed-43936632015-04-13 The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord Blood Abbasi, Parvaneh Shamsasenjan, Karim Movassaghpour Akbari, Ali Akbar Akbarzadehlaleh, Parvin Dehdilani, Nima Ejtehadifar, Mostafa Cell J Original Article OBJECTIVE: The peroxisome proliferator-activated receptors (PPARs) are a group of nu- clear receptor proteins whose functions as transcription factors regulate gene expres- sions. PPARs play essential roles in the regulation of cellular differentiation, development, and metabolism (carbohydrate, lipid, protein), and tumorigenesis of higher organisms. This study attempts to determine the effect of baicalin, a PPARγ activator, on erythroid differentiation of cluster of differentiation 133(+)(CD133(+)) cord blood hematopoietic stem cells (HSCs). MATERIALS AND METHODS: In this experimental study, in order to investigate the effects of the PPARγ agonists baicalin and troglitazone on erythropoiesis, we isolated CD133(+) cells from human umbilical cord blood using the MACS method. Isolated cells were cultured in erythroid-inducing medium with or without various amounts of the two PPARγ activa- tors (baicalin and troglitazone). Erythroid differentiation of CD133(+)cord blood HSCs were assessed using microscopic morphology analysis, flow cytometric analysis of erythroid surface markers transferrin receptor (TfR) and glycophorin A (GPA) and bycolony forming assay. RESULTS: Microscopic and flow cytometric analysis revealed the erythroid differentiation of CD133(+)cord blood HSCs under applied erythroid inducing conditions. Our flow cytometric data showed that the TfR and GPA positive cell population diminished significantly in the presence of either troglitazone or baicalin. The suppression of erythroid differentiation in response to PPARγ agonists was dose-dependent. Erythroid colony-forming ability of HSC decreased significantly after treatment with both PPARγ agonists but troglitazone had a markedly greater effect. CONCLUSION: Our results have demonstrated that PPARγ agonists modulate erythroid dif- ferentiation of CD133(+)HSCs, and therefore play an important role in regulation of normal erythropoiesis under physiologic conditions. Thus, considering the availability and applica- tion of this herbal remedy for treatment of a wide range of diseases, the inhibitory effect of baicalin on erythropoiesis should be noted. Royan Institute 2015 2015-04-08 /pmc/articles/PMC4393663/ /pubmed/25870831 Text en Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Abbasi, Parvaneh
Shamsasenjan, Karim
Movassaghpour Akbari, Ali Akbar
Akbarzadehlaleh, Parvin
Dehdilani, Nima
Ejtehadifar, Mostafa
The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord Blood
title The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord Blood
title_full The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord Blood
title_fullStr The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord Blood
title_full_unstemmed The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord Blood
title_short The Effect of Baicalin as A PPAR Activator on Erythroid Differentiation of CD133(+)Hematopoietic Stem Cells in Umbilical Cord Blood
title_sort effect of baicalin as a ppar activator on erythroid differentiation of cd133(+)hematopoietic stem cells in umbilical cord blood
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393663/
https://www.ncbi.nlm.nih.gov/pubmed/25870831
work_keys_str_mv AT abbasiparvaneh theeffectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT shamsasenjankarim theeffectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT movassaghpourakbarialiakbar theeffectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT akbarzadehlalehparvin theeffectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT dehdilaninima theeffectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT ejtehadifarmostafa theeffectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT abbasiparvaneh effectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT shamsasenjankarim effectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT movassaghpourakbarialiakbar effectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT akbarzadehlalehparvin effectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT dehdilaninima effectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood
AT ejtehadifarmostafa effectofbaicalinasapparactivatoronerythroiddifferentiationofcd133hematopoieticstemcellsinumbilicalcordblood